Financials Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:31 2024-06-11 am EDT 5-day change 1st Jan Change
586.3 INR +2.74% Intraday chart for Wockhardt Limited +14.07% +38.16%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 80,373 49,034 19,118 45,869 37,972 22,175
Enterprise Value (EV) 1 105,423 78,805 52,659 69,944 56,132 42,855
P/E ratio -13.2 x -25.2 x -27.6 x 6.68 x -13 x -3.97 x
Yield - - - - - -
Capitalization / Revenue 2.05 x 1.18 x 0.67 x 1.69 x 1.18 x 0.84 x
EV / Revenue 2.69 x 1.9 x 1.85 x 2.58 x 1.74 x 1.62 x
EV / EBITDA -173 x 61.6 x 169 x -49.1 x 24.8 x 171 x
EV / FCF -254 x -25.7 x 61.8 x -19.1 x 22.8 x -90 x
FCF Yield -0.39% -3.89% 1.62% -5.24% 4.39% -1.11%
Price to Book 2.86 x 1.88 x 0.73 x 1.39 x 1 x 0.67 x
Nbr of stocks (in thousands) 110,630 110,686 110,735 110,781 144,053 144,088
Reference price 2 726.5 443.0 172.6 414.0 263.6 153.9
Announcement Date 8/5/18 7/17/19 7/5/20 7/8/21 7/20/22 7/21/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 39,245 41,584 28,440 27,083 32,300 26,510
EBITDA 1 -610.7 1,279 312 -1,425 2,260 250
EBIT 1 -2,050 -310.9 -1,264 -3,066 510 -1,500
Operating Margin -5.22% -0.75% -4.44% -11.32% 1.58% -5.66%
Earnings before Tax (EBT) 1 -6,412 -3,003 -3,420 -5,683 -4,110 -6,240
Net income 1 -6,083 -1,945 -692.2 6,861 -2,440 -5,590
Net margin -15.5% -4.68% -2.43% 25.33% -7.55% -21.09%
EPS 2 -55.01 -17.58 -6.252 61.95 -20.24 -38.80
Free Cash Flow 1 -414.7 -3,062 852.7 -3,666 2,466 -476.2
FCF margin -1.06% -7.36% 3% -13.53% 7.64% -1.8%
FCF Conversion (EBITDA) - - 273.29% - 109.13% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/5/18 7/17/19 7/5/20 7/8/21 7/20/22 7/21/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 25,050 29,772 33,541 24,075 18,160 20,680
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -41.02 x 23.28 x 107.5 x -16.9 x 8.035 x 82.72 x
Free Cash Flow 1 -415 -3,062 853 -3,666 2,466 -476
ROE (net income / shareholders' equity) -19.3% -6.99% -4.55% -8.7% -7.01% -15.8%
ROA (Net income/ Total Assets) -1.49% -0.24% -0.99% -2.4% 0.4% -1.18%
Assets 1 408,009 800,865 70,210 -285,561 -613,065 474,815
Book Value Per Share 2 254.0 236.0 235.0 299.0 263.0 228.0
Cash Flow per Share 2 81.10 35.90 19.80 21.00 25.70 6.250
Capex 1 3,074 2,749 1,724 805 1,180 420
Capex / Sales 7.83% 6.61% 6.06% 2.97% 3.65% 1.58%
Announcement Date 8/5/18 7/17/19 7/5/20 7/8/21 7/20/22 7/21/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. WOCKPHARMA Stock
  4. Financials Wockhardt Limited